These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 9608883

  • 21. Fenofibrate reduces atherogenesis in ApoE*3Leiden mice: evidence for multiple antiatherogenic effects besides lowering plasma cholesterol.
    Kooistra T, Verschuren L, de Vries-van der Weij J, Koenig W, Toet K, Princen HM, Kleemann R.
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2322-30. PubMed ID: 16873727
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of glycosphingolipid synthesis induces a profound reduction of plasma cholesterol and inhibits atherosclerosis development in APOE*3 Leiden and low-density lipoprotein receptor-/- mice.
    Bietrix F, Lombardo E, van Roomen CP, Ottenhoff R, Vos M, Rensen PC, Verhoeven AJ, Aerts JM, Groen AK.
    Arterioscler Thromb Vasc Biol; 2010 May; 30(5):931-7. PubMed ID: 20167657
    [Abstract] [Full Text] [Related]

  • 23. Effect of fenofibrate on plasma lipoprotein composition and kinetics in patients with complete hepatic lipase deficiency.
    Ruel IL, Lamarche B, Mauger JF, Badellino KO, Cohn JS, Marcil M, Couture P.
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2600-7. PubMed ID: 16224048
    [Abstract] [Full Text] [Related]

  • 24. Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia.
    Vigna GB, Donega P, Passaro A, Zanca R, Cattin L, Fonda M, Pauciullo P, Marotta G, Fellin R, Gasparrini S, Piliego T.
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):234-43. PubMed ID: 10656170
    [Abstract] [Full Text] [Related]

  • 25. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 26. Combination of dietary phytosterols plus niacin or fenofibrate: effects on lipid profile and atherosclerosis in apo E-KO mice.
    Yeganeh B, Moshtaghi-Kashanian GR, Declercq V, Moghadasian MH.
    J Nutr Biochem; 2005 Apr; 16(4):222-8. PubMed ID: 15808326
    [Abstract] [Full Text] [Related]

  • 27. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
    Shi W, Wang X, Wong J, Hedrick CC, Wong H, Castellani LW, Lusis AJ.
    Biochem Biophys Res Commun; 2004 Apr 23; 317(1):223-9. PubMed ID: 15047172
    [Abstract] [Full Text] [Related]

  • 28. Familial dysbetalipoproteinemia associated with apolipoprotein E3-Leiden in an extended multigeneration pedigree.
    de Knijff P, van den Maagdenberg AM, Stalenhoef AF, Leuven JA, Demacker PN, Kuyt LP, Frants RR, Havekes LM.
    J Clin Invest; 1991 Aug 23; 88(2):643-55. PubMed ID: 1864973
    [Abstract] [Full Text] [Related]

  • 29. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis.
    Post SM, de Roos B, Vermeulen M, Afman L, Jong MC, Dahlmans VE, Havekes LM, Stellaard F, Katan MB, Princen HM.
    Arterioscler Thromb Vasc Biol; 2000 Jun 23; 20(6):1551-6. PubMed ID: 10845871
    [Abstract] [Full Text] [Related]

  • 30. Response of apolipoprotein E*3-Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data.
    de Roos B, Duivenvoorden I, Rucklidge G, Reid M, Ross K, Lamers RJ, Voshol PJ, Havekes LM, Teusink B.
    FASEB J; 2005 May 23; 19(7):813-5. PubMed ID: 15755870
    [Abstract] [Full Text] [Related]

  • 31. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y, Liu XQ, Rall SC, Mahley RW.
    J Biol Chem; 1998 Jul 10; 273(28):17483-90. PubMed ID: 9651338
    [Abstract] [Full Text] [Related]

  • 32. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
    Bisgaier CL, Essenburg AD, Barnett BC, Auerbach BJ, Haubenwallner S, Leff T, White AD, Creger P, Pape ME, Rea TJ, Newton RS.
    J Lipid Res; 1998 Jan 10; 39(1):17-30. PubMed ID: 9469582
    [Abstract] [Full Text] [Related]

  • 33. Effects of hypolipidemic drugs on the expression of genes involved in high density lipoprotein metabolism in the rat.
    Staels B, Van Tol A, Fruchart JC, Auwerx J.
    Isr J Med Sci; 1996 Jun 10; 32(6):490-8. PubMed ID: 8682657
    [Abstract] [Full Text] [Related]

  • 34. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.
    Post SM, Groenendijk M, Solaas K, Rensen PC, Princen HM.
    Arterioscler Thromb Vasc Biol; 2004 Apr 10; 24(4):768-74. PubMed ID: 14962946
    [Abstract] [Full Text] [Related]

  • 35. Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia.
    van den Maagdenberg AM, Hofker MH, Krimpenfort PJ, de Bruijn I, van Vlijmen B, van der Boom H, Havekes LM, Frants RR.
    J Biol Chem; 1993 May 15; 268(14):10540-5. PubMed ID: 7683682
    [Abstract] [Full Text] [Related]

  • 36. A comparative study of the efficacy of simvastatin and gemfibrozil in combined hyperlipoproteinemia: prediction of response by baseline lipids, apo E genotype, lipoprotein(a) and insulin.
    Nestel P, Simons L, Barter P, Clifton P, Colquhoun D, Hamilton-Craig I, Sikaris K, Sullivan D.
    Atherosclerosis; 1997 Mar 21; 129(2):231-9. PubMed ID: 9105566
    [Abstract] [Full Text] [Related]

  • 37. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor.
    van Dijk KW, van Vlijmen BJ, van der Zee A, van't Hof B, van der Boom H, Kobayashi K, Chan L, Havekes LM, Hofker MH.
    Arterioscler Thromb Vasc Biol; 1998 Jan 21; 18(1):7-12. PubMed ID: 9445249
    [Abstract] [Full Text] [Related]

  • 38. Impaired lipid metabolism in aged mice as revealed by fasting-induced expression of apolipoprotein mRNAs in the liver and changes in serum lipids.
    Araki S, Okazaki M, Goto S.
    Gerontology; 2004 Jan 21; 50(4):206-15. PubMed ID: 15258425
    [Abstract] [Full Text] [Related]

  • 39. No effect of fibrates on synthesis of apolipoprotein(a) in primary cultures of cynomolgus monkey and human hepatocytes: apolipoprotein A-I synthesis increased.
    Neele DM, Kaptein A, Huisman H, de Wit EC, Princen HM.
    Biochem Biophys Res Commun; 1998 Mar 17; 244(2):374-8. PubMed ID: 9514936
    [Abstract] [Full Text] [Related]

  • 40. Synthesis and hypolipidemic evaluation of beta-alkylaminopropiophenone and beta-alkylaminopropio-2'-naphthone derivatives in rodents.
    Huang Y, Hall IH.
    Pharmazie; 1996 Apr 17; 51(4):199-206. PubMed ID: 8628737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.